Cargando…

Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia

Degenerative cerebellar ataxias have no pharmacological or rehabilitation evidence-based treatment so far. Patients remain highly symptomatic and disabled despite receiving the best medical treatment available. This study investigates the clinical and neurophysiologic outcomes of the use of subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexoudi, Athanasia, Vlachakis, Eustathios, Deftereos, Spyros N, Korfias, Stefanos, Gatzonis, Stylianos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150336/
https://www.ncbi.nlm.nih.gov/pubmed/37139025
http://dx.doi.org/10.7759/cureus.36991
_version_ 1785035341556613120
author Alexoudi, Athanasia
Vlachakis, Eustathios
Deftereos, Spyros N
Korfias, Stefanos
Gatzonis, Stylianos
author_facet Alexoudi, Athanasia
Vlachakis, Eustathios
Deftereos, Spyros N
Korfias, Stefanos
Gatzonis, Stylianos
author_sort Alexoudi, Athanasia
collection PubMed
description Degenerative cerebellar ataxias have no pharmacological or rehabilitation evidence-based treatment so far. Patients remain highly symptomatic and disabled despite receiving the best medical treatment available. This study investigates the clinical and neurophysiologic outcomes of the use of subcutaneous cortex stimulation (in keeping with the established protocol of peripheral nerve stimulation applied in chronic intractable pain) in degenerative ataxia. We report a case of a 37-year-old right-handed man who developed moderate degenerative cerebellar ataxia at the age of 18 years. His symptoms progressively worsened and impaired his daily activities. We observed clinical improvement for at least one month following an initial two-week trial of parietal transcranial direct current stimulation. Although preoperative non-invasive transcranial neuromodulation application does not predict invasive cortex stimulation outcome, we pursued a long-lasting effect by implanting parietal and occipital subcutaneous electrodes. At 12 months following permanent implantation, the patient exhibited amelioration of his symptoms and a change in neurophysiologic parameters. Central neuromodulation based on peripheral stimulation is considered part of neurosurgical clinical practice for the treatment of a variety of neurological disorders. The underpinning neurophysiological mechanism that explains the effectiveness of the method has not been fully elucidated. We believe that further studies are warranted to investigate these promising results in such devastating conditions.
format Online
Article
Text
id pubmed-10150336
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101503362023-05-02 Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia Alexoudi, Athanasia Vlachakis, Eustathios Deftereos, Spyros N Korfias, Stefanos Gatzonis, Stylianos Cureus Neurology Degenerative cerebellar ataxias have no pharmacological or rehabilitation evidence-based treatment so far. Patients remain highly symptomatic and disabled despite receiving the best medical treatment available. This study investigates the clinical and neurophysiologic outcomes of the use of subcutaneous cortex stimulation (in keeping with the established protocol of peripheral nerve stimulation applied in chronic intractable pain) in degenerative ataxia. We report a case of a 37-year-old right-handed man who developed moderate degenerative cerebellar ataxia at the age of 18 years. His symptoms progressively worsened and impaired his daily activities. We observed clinical improvement for at least one month following an initial two-week trial of parietal transcranial direct current stimulation. Although preoperative non-invasive transcranial neuromodulation application does not predict invasive cortex stimulation outcome, we pursued a long-lasting effect by implanting parietal and occipital subcutaneous electrodes. At 12 months following permanent implantation, the patient exhibited amelioration of his symptoms and a change in neurophysiologic parameters. Central neuromodulation based on peripheral stimulation is considered part of neurosurgical clinical practice for the treatment of a variety of neurological disorders. The underpinning neurophysiological mechanism that explains the effectiveness of the method has not been fully elucidated. We believe that further studies are warranted to investigate these promising results in such devastating conditions. Cureus 2023-04-01 /pmc/articles/PMC10150336/ /pubmed/37139025 http://dx.doi.org/10.7759/cureus.36991 Text en Copyright © 2023, Alexoudi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Alexoudi, Athanasia
Vlachakis, Eustathios
Deftereos, Spyros N
Korfias, Stefanos
Gatzonis, Stylianos
Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia
title Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia
title_full Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia
title_fullStr Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia
title_full_unstemmed Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia
title_short Implantable Subcutaneous Peripheral Nerve Stimulation Improves Degenerative Ataxia
title_sort implantable subcutaneous peripheral nerve stimulation improves degenerative ataxia
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150336/
https://www.ncbi.nlm.nih.gov/pubmed/37139025
http://dx.doi.org/10.7759/cureus.36991
work_keys_str_mv AT alexoudiathanasia implantablesubcutaneousperipheralnervestimulationimprovesdegenerativeataxia
AT vlachakiseustathios implantablesubcutaneousperipheralnervestimulationimprovesdegenerativeataxia
AT deftereosspyrosn implantablesubcutaneousperipheralnervestimulationimprovesdegenerativeataxia
AT korfiasstefanos implantablesubcutaneousperipheralnervestimulationimprovesdegenerativeataxia
AT gatzonisstylianos implantablesubcutaneousperipheralnervestimulationimprovesdegenerativeataxia